ID24374A - Komposisi-komposisi parenteral alatrofloksasin - Google Patents

Komposisi-komposisi parenteral alatrofloksasin

Info

Publication number
ID24374A
ID24374A IDW20000200A ID20000200A ID24374A ID 24374 A ID24374 A ID 24374A ID W20000200 A IDW20000200 A ID W20000200A ID 20000200 A ID20000200 A ID 20000200A ID 24374 A ID24374 A ID 24374A
Authority
ID
Indonesia
Prior art keywords
alatrofloxasin
parenteral compositions
parenteral
compositions
Prior art date
Application number
IDW20000200A
Other languages
English (en)
Indonesian (id)
Inventor
Robert Mark Guinn
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of ID24374A publication Critical patent/ID24374A/id

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06191Dipeptides containing heteroatoms different from O, S, or N
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)
IDW20000200A 1997-08-01 1998-07-23 Komposisi-komposisi parenteral alatrofloksasin ID24374A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5424697P 1997-08-01 1997-08-01

Publications (1)

Publication Number Publication Date
ID24374A true ID24374A (id) 2000-07-13

Family

ID=21989735

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20000200A ID24374A (id) 1997-08-01 1998-07-23 Komposisi-komposisi parenteral alatrofloksasin

Country Status (40)

Country Link
US (1) US6194429B1 (pt)
EP (1) EP1000086B1 (pt)
JP (1) JP3463928B2 (pt)
KR (1) KR20010022495A (pt)
CN (1) CN1265671A (pt)
AP (1) AP1031A (pt)
AR (1) AR015417A1 (pt)
AT (1) ATE259827T1 (pt)
AU (1) AU734863B2 (pt)
BG (1) BG104105A (pt)
BR (1) BR9811580A (pt)
CA (1) CA2296466C (pt)
CO (1) CO4970688A1 (pt)
DE (1) DE69821767T2 (pt)
DK (1) DK1000086T3 (pt)
DZ (1) DZ2576A1 (pt)
EA (1) EA002120B1 (pt)
ES (1) ES2214716T3 (pt)
GT (1) GT199800112A (pt)
HN (1) HN1998000106A (pt)
HR (1) HRP980417B1 (pt)
HU (1) HUP0004793A3 (pt)
ID (1) ID24374A (pt)
IL (1) IL134156A0 (pt)
IS (1) IS5339A (pt)
MA (1) MA24626A1 (pt)
NO (1) NO20000485L (pt)
NZ (1) NZ502249A (pt)
OA (1) OA11281A (pt)
PA (1) PA8456701A1 (pt)
PE (1) PE103799A1 (pt)
PL (1) PL338477A1 (pt)
PT (1) PT1000086E (pt)
SK (1) SK1012000A3 (pt)
TN (1) TNSN98146A1 (pt)
TW (1) TW538043B (pt)
UY (1) UY25113A1 (pt)
WO (1) WO1999006430A1 (pt)
YU (1) YU2500A (pt)
ZA (1) ZA986874B (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL148820A0 (en) * 1999-10-08 2002-09-12 Smithkline Beecham Corp Fab i inhibitors
EP1121933A1 (en) * 2000-02-02 2001-08-08 Pfizer Products Inc. Premixed alatrofloxacin injectable compositions
WO2003088897A2 (en) * 2001-04-06 2003-10-30 Affinium Pharmaceuticals, Inc. Fab i inhibitors
DK1575951T3 (da) * 2002-12-06 2014-09-15 Debiopharm Int Sa Heterocykliske forbindelser, fremgangsmåder til fremstilling deraf og deres anvendelse i terapi
EP1608377B1 (en) 2003-03-17 2008-10-01 Affinium Pharmaceuticals, Inc. Pharmaceutical compositions comprising inhibitors of fab i and further antibiotics
CA2467321A1 (en) * 2004-05-14 2005-11-14 Paul J. Santerre Polymeric coupling agents and pharmaceutically-active polymers made therefrom
JP5087406B2 (ja) 2004-06-04 2012-12-05 アフィニウム ファーマシューティカルズ, インク. 治療薬ならびにその製造方法および使用方法
JP2009518399A (ja) * 2005-12-05 2009-05-07 アフィニウム ファーマシューティカルズ, インク. Fabi阻害剤および抗菌剤としてのヘテロ環アクリルアミド化合物
WO2008009122A1 (en) 2006-07-20 2008-01-24 Affinium Pharmaceuticals, Inc. Acrylamide derivatives as fab i inhibitors
WO2008098374A1 (en) 2007-02-16 2008-08-21 Affinium Pharmaceuticals, Inc. Salts, prodrugs and polymorphs of fab i inhibitors
DK2861608T3 (da) 2012-06-19 2019-06-24 Debiopharm Int Sa Prodrug-derivater af (e)-n-methyl-n-((3-methylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamid
KR20160144499A (ko) * 2014-04-25 2016-12-16 노렉스, 인크. 신경활성 펩타이드의 안정한 조성물
CN108778286A (zh) 2016-02-26 2018-11-09 德彪药业国际股份公司 用于治疗糖尿病足感染的药物
CN111971292A (zh) 2018-02-02 2020-11-20 波纹疗法公司 包含类固醇二聚体的玻璃制剂及其用途
WO2021220061A2 (en) 2020-05-01 2021-11-04 Ripple Therapeutics Corporation Heterodimer compositions and methods for the treatment of ocular disorders

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3713672A1 (de) 1987-04-24 1988-11-17 Bayer Ag Verfahren zur herstellung von parenteral verabreichbaren chinoloncarbonsaeuren
US5164402A (en) 1989-08-16 1992-11-17 Pfizer Inc Azabicyclo quinolone and naphthyridinone carboxylic acids
US5256791A (en) 1992-03-02 1993-10-26 Pfizer Inc. Preparation of intermediates in the synthesis of quinoline antibiotics
CN1141634A (zh) 1994-01-18 1997-01-29 辉瑞大药厂 萘啶酮羧酸盐的制备方法和中间体
TW420610B (en) 1994-04-07 2001-02-01 Pfizer A pharmaceutical composition for treating a H. pylori infection or gastric or duodenal ulcers
US5475116A (en) 1994-04-29 1995-12-12 Pfizer Inc. Aza bicyclo[3,1,0]hexane intermediates useful in the synthesis of quinolones
ES2117426T3 (es) 1995-06-06 1998-08-01 Pfizer Forma cristalina de la sal anhidra compuesta de los acidos 7-((1a,5a,6a)-6-amino-3-azabiciclo(3.1.0.)hex-3-il)-6-fluoro-1-(2,4-difluorofenil)-1,4-dihidro-4-oxo-1,8-naftiridina-3-carboxilico y metanosulfonico.
ATE221544T1 (de) 1995-06-15 2002-08-15 Pfizer Verfahren zur herstellung von derivaten der ein peptid enthaltenden azabizylo-naphtyridin- carbonsäure
DE69617027T2 (de) 1995-08-29 2002-03-21 Pfizer Inc., New York Polymorphs von prodrug 6-n(l-ala-l-ala)-trovafloxacin
CA2229786C (en) 1995-08-29 2002-02-19 David Bruning Joseph Zwitterionic forms of trovafloxacin
GB9524466D0 (en) 1995-11-30 1996-01-31 Pfizer Ltd Process
JPH1087617A (ja) 1996-07-09 1998-04-07 Pfizer Inc キノリン系抗生物質の合成に有用な中間体の製法

Also Published As

Publication number Publication date
CO4970688A1 (es) 2000-11-07
WO1999006430A1 (en) 1999-02-11
HN1998000106A (es) 1999-01-08
DE69821767D1 (de) 2004-03-25
PL338477A1 (en) 2000-11-06
TW538043B (en) 2003-06-21
JP2001512133A (ja) 2001-08-21
MA24626A1 (fr) 1999-04-01
DK1000086T3 (da) 2004-05-17
EP1000086B1 (en) 2004-02-18
CA2296466A1 (en) 1999-02-11
HRP980417A2 (en) 1999-08-31
BR9811580A (pt) 2000-08-22
CN1265671A (zh) 2000-09-06
AR015417A1 (es) 2001-05-02
HUP0004793A3 (en) 2001-10-29
ATE259827T1 (de) 2004-03-15
YU2500A (sh) 2002-09-19
BG104105A (bg) 2000-08-31
KR20010022495A (ko) 2001-03-15
JP3463928B2 (ja) 2003-11-05
TNSN98146A1 (fr) 2005-03-15
HUP0004793A2 (hu) 2001-04-28
NO20000485L (no) 2000-03-27
HRP980417B1 (en) 2002-10-31
AP9801310A0 (en) 1998-09-30
AU734863B2 (en) 2001-06-21
ES2214716T3 (es) 2004-09-16
SK1012000A3 (en) 2000-09-12
DE69821767T2 (de) 2005-01-13
AU8236898A (en) 1999-02-22
IL134156A0 (en) 2001-04-30
GT199800112A (es) 2000-01-15
DZ2576A1 (fr) 2003-02-22
PE103799A1 (es) 1999-10-25
AP1031A (en) 2001-12-21
EA002120B1 (ru) 2001-12-24
ZA986874B (en) 2000-01-31
EA200000086A1 (ru) 2000-08-28
NO20000485D0 (no) 2000-01-31
PA8456701A1 (es) 2000-05-24
CA2296466C (en) 2003-04-15
OA11281A (en) 2002-11-19
IS5339A (is) 2000-01-14
NZ502249A (en) 2001-11-30
US6194429B1 (en) 2001-02-27
PT1000086E (pt) 2004-05-31
EP1000086A1 (en) 2000-05-17
UY25113A1 (es) 2000-12-29

Similar Documents

Publication Publication Date Title
ID22931A (id) Komposisi-komposisi herbisidal
DK1298194T3 (da) Staniolholdige sammensætninger
CY2012029I2 (el) Nεα μορφη της 5-ομεπραζολης
PT945132E (pt) Composicao de ibuprofeno
DE69832516D1 (de) Isoflavon-enthaltende zusammensetzungen
ID16251A (id) Komposisi-komposisi pembasmi kuman
ID26549A (id) Komposisi-komposisi epotilon
ATE367793T1 (de) Schweisshemmende zusammensetzungen
FI974241A0 (fi) BPM-15 -koostumukset
DE69803761D1 (de) Schmierölzusammensetzungen
DE69826477D1 (de) Flammhemmende zusammensetzungen
DE69919953D1 (de) Funktionelle zusammensetzungen
ATE469550T1 (de) Antiparasitäre zusammensetzungen
ID24458A (id) Modifikasi rheologi in-sito poliolefin
ID25508A (id) Komposisi dematologis
DE69935172D1 (de) Imidosilan Zusammensetzungen
DE69829605D1 (de) Chondroitinase enthaltende Zusammensetzungen
DE69708866D1 (de) Mikroverkapselte zusammensetzungen
DE69733072D1 (de) Farbschonende zusammensetzungen
DE69719442D1 (de) Frisierschaum-Zusammensetzungen
PT1014987E (pt) Composicoes orais de levosimendano
ID27889A (id) Komposisi-komposisi kopolimer polisiklik
DE69617029D1 (de) Organoton-zusammensetzungen
NO984662L (no) Vann-i-olje-emulsjonsgj°dningsstoff-sammensetninger
ID24374A (id) Komposisi-komposisi parenteral alatrofloksasin